Company / Capital Expenditures
Armata Pharmaceuticals, Inc. Capital Expenditures History
FY2014-FY2014 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.2M
FY2014
5-year range
$1.2M / $1.2M
FY2014-FY2014
Trend
-
vs FY2013
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$1M in FY2014.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -12.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2014 | $1.2M | - |
As of FY2014 · SEC 10-K · Updated Jun 21, 2026